Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode.

Amsterdam JD, Shults J.

J Clin Psychopharmacol. 2010 Jun;30(3):306-11. doi: 10.1097/JCP.0b013e3181da5300.

PMID:
20473068
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.

Amsterdam JD, Wang CH, Shwarz M, Shults J.

J Affect Disord. 2009 Jan;112(1-3):219-30. doi: 10.1016/j.jad.2008.03.029. Epub 2008 May 16.

PMID:
18486235
[PubMed - indexed for MEDLINE]
3.

Effectiveness and mood conversion rate of short-term fluoxetine monotherapy in patients with rapid cycling bipolar II depression versus patients with nonrapid cycling bipolar II depression.

Amsterdam JD, Luo L, Shults J.

J Clin Psychopharmacol. 2013 Jun;33(3):420-4. doi: 10.1097/JCP.0b013e31828ea89e.

PMID:
23609385
[PubMed - indexed for MEDLINE]
4.

Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.

Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.

J Clin Psychiatry. 2009 Oct;70(10):1424-31. doi: 10.4088/JCP.08m04772gre.

PMID:
19906346
[PubMed - indexed for MEDLINE]
5.

Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.

Amsterdam JD, Shults J.

Am J Psychiatry. 2010 Jul;167(7):792-800. doi: 10.1176/appi.ajp.2009.09020284. Epub 2010 Apr 1.

PMID:
20360317
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.

Amsterdam JD, Shults J.

J Clin Psychopharmacol. 2008 Apr;28(2):171-81. doi: 10.1097/JCP.0b013e318166c4e6.

PMID:
18344727
[PubMed - indexed for MEDLINE]
7.

Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study.

Amsterdam JD, Shults J.

Int Clin Psychopharmacol. 2005 Sep;20(5):257-64.

PMID:
16096516
[PubMed - indexed for MEDLINE]
8.

Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate.

Amsterdam JD, Shults J, Brunswick DJ, Hundert M.

Bipolar Disord. 2004 Feb;6(1):75-81.

PMID:
14996144
[PubMed - indexed for MEDLINE]
9.

Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.

Amsterdam JD, Garcia-España F, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, Schweizer E, Beasley C.

J Clin Psychopharmacol. 1998 Dec;18(6):435-40.

PMID:
9864074
[PubMed - indexed for MEDLINE]
10.

Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder.

Amsterdam JD, Luo L, Shults J.

Br J Psychiatry. 2013 Apr;202(4):301-6. doi: 10.1192/bjp.bp.111.104711. Epub 2012 Oct 25.

PMID:
23099447
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
12.

A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.

Corya SA, Perlis RH, Keck PE Jr, Lin DY, Case MG, Williamson DJ, Tohen MF.

J Clin Psychiatry. 2006 May;67(5):798-806.

PMID:
16841630
[PubMed - indexed for MEDLINE]
13.

ECNP consensus meeting. Bipolar depression. Nice, March 2007.

Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.

Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Review.

PMID:
18501566
[PubMed - indexed for MEDLINE]
14.
15.

Role of risperidone in bipolar II: an open 6-month study.

Vieta E, Gastó C, Colom F, Reinares M, Martínez-Arán A, Benabarre A, Akiskal HS.

J Affect Disord. 2001 Dec;67(1-3):213-9.

PMID:
11869771
[PubMed - indexed for MEDLINE]
16.

Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.

McElroy SL, Martens BE, Winstanley EL, Creech R, Malhotra S, Keck PE Jr.

J Affect Disord. 2010 Jul;124(1-2):157-63. doi: 10.1016/j.jad.2009.11.014. Epub 2009 Dec 5.

PMID:
19963274
[PubMed - indexed for MEDLINE]
17.

Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy.

Amsterdam JD, Wang G, Shults J.

Acta Psychiatr Scand. 2010 Mar;121(3):201-8. doi: 10.1111/j.1600-0447.2009.01462.x. Epub 2009 Aug 19.

PMID:
19694630
[PubMed - indexed for MEDLINE]
18.

Ziprasidone monotherapy in bipolar II depression: an open trial.

Liebowitz MR, Salmán E, Mech A, Dunner D, Johnson AE, Akhtar J, Pratap R.

J Affect Disord. 2009 Nov;118(1-3):205-8. doi: 10.1016/j.jad.2009.01.022. Epub 2009 Mar 4.

PMID:
19264363
[PubMed - indexed for MEDLINE]
19.

Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.

Hantouche EG, Akiskal HS, Lancrenon S, Chatenêt-Duchêne L.

J Affect Disord. 2005 Feb;84(2-3):243-9.

PMID:
15708422
[PubMed - indexed for MEDLINE]
20.

Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.

Sanger TM, Grundy SL, Gibson PJ, Namjoshi MA, Greaney MG, Tohen MF.

J Clin Psychiatry. 2001 Apr;62(4):273-81.

PMID:
11379842
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk